We show that anti-SEMA4D antibody therapy not only prevents, but reverses, many Rett syndrome-specific phenotypes, including coordination, cognition, locomotion, and respiratory deficits in both pre-symptomatic and symptomatic mice. The gene discussed is SEMA4D; the disease is atypical Rett syndrome.